DD222016A5 - Verfahren zur herstellung von neuen beta-lactam-antibiotika - Google Patents

Verfahren zur herstellung von neuen beta-lactam-antibiotika Download PDF

Info

Publication number
DD222016A5
DD222016A5 DD83255479A DD25547983A DD222016A5 DD 222016 A5 DD222016 A5 DD 222016A5 DD 83255479 A DD83255479 A DD 83255479A DD 25547983 A DD25547983 A DD 25547983A DD 222016 A5 DD222016 A5 DD 222016A5
Authority
DD
German Democratic Republic
Prior art keywords
amino
item
group
hydrogen
radicals
Prior art date
Application number
DD83255479A
Other languages
German (de)
English (en)
Inventor
William A Slusarchyk
David R Kronenthal
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of DD222016A5 publication Critical patent/DD222016A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DD83255479A 1982-10-06 1983-10-06 Verfahren zur herstellung von neuen beta-lactam-antibiotika DD222016A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43317582A 1982-10-06 1982-10-06

Publications (1)

Publication Number Publication Date
DD222016A5 true DD222016A5 (de) 1985-05-08

Family

ID=23719123

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83255479A DD222016A5 (de) 1982-10-06 1983-10-06 Verfahren zur herstellung von neuen beta-lactam-antibiotika

Country Status (27)

Country Link
JP (1) JPS5988462A (xx)
KR (1) KR900005132B1 (xx)
AU (1) AU568312B2 (xx)
BE (1) BE897883A (xx)
CA (1) CA1253501A (xx)
CH (1) CH658858A5 (xx)
DD (1) DD222016A5 (xx)
DE (1) DE3336262A1 (xx)
DK (1) DK457983A (xx)
ES (1) ES8504814A1 (xx)
FI (1) FI833631A (xx)
FR (1) FR2534253B1 (xx)
GB (1) GB2129428B (xx)
GR (1) GR79704B (xx)
HU (1) HU190507B (xx)
IE (1) IE56600B1 (xx)
IL (1) IL69917A (xx)
IT (1) IT1171722B (xx)
LU (1) LU85033A1 (xx)
NL (1) NL8303410A (xx)
NO (1) NO833626L (xx)
NZ (1) NZ205642A (xx)
PH (1) PH24175A (xx)
PT (1) PT77458B (xx)
SE (1) SE8305509L (xx)
SU (1) SU1318146A3 (xx)
ZA (1) ZA837491B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135194A1 (en) * 1983-09-16 1985-03-27 Takeda Chemical Industries, Ltd. Azetidinones and their production
WO1985004876A1 (en) * 1984-04-24 1985-11-07 Takeda Chemical Industries, Ltd. 2-azetidinone derivatives and process for their preparation
US4581170A (en) * 1984-08-03 1986-04-08 E. R. Squibb & Sons, Inc. N-hydroxyl protecting groups and process and intermediates for the preparation of 3-acylamino-1-hydroxy-2-azetidinones
EP0171064B1 (en) * 1984-08-06 1995-07-12 Fujisawa Pharmaceutical Co., Ltd. Azetidinone derivative and processes for production thereof
UY34585A (es) 2012-01-24 2013-09-02 Aicuris Gmbh & Co Kg Compuestos b-lactámicos sustituidos con amidina, su preparación y uso

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337197A (en) * 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates

Also Published As

Publication number Publication date
IL69917A (en) 1987-10-20
AU568312B2 (en) 1987-12-24
GR79704B (xx) 1984-10-31
KR900005132B1 (ko) 1990-07-20
SE8305509D0 (sv) 1983-10-06
BE897883A (fr) 1984-03-30
ES526282A0 (es) 1985-04-16
FI833631A0 (fi) 1983-10-06
JPS5988462A (ja) 1984-05-22
IE832354L (en) 1984-04-06
IE56600B1 (en) 1991-10-09
AU1993983A (en) 1984-04-12
LU85033A1 (fr) 1984-05-10
FR2534253A1 (fr) 1984-04-13
PH24175A (en) 1990-03-22
SU1318146A3 (ru) 1987-06-15
DE3336262A1 (de) 1984-04-12
NO833626L (no) 1984-04-09
CH658858A5 (fr) 1986-12-15
ES8504814A1 (es) 1985-04-16
KR840006337A (ko) 1984-11-29
PT77458A (en) 1983-11-01
ZA837491B (en) 1984-06-27
DK457983D0 (da) 1983-10-04
GB8326626D0 (en) 1983-11-09
NL8303410A (nl) 1984-05-01
DK457983A (da) 1984-04-07
IT8323172A0 (it) 1983-10-06
FI833631A (fi) 1984-04-07
SE8305509L (sv) 1984-04-07
HU190507B (en) 1986-09-29
NZ205642A (en) 1986-08-08
IL69917A0 (en) 1984-01-31
GB2129428B (en) 1986-03-19
FR2534253B1 (fr) 1985-07-26
IT1171722B (it) 1987-06-10
CA1253501A (en) 1989-05-02
GB2129428A (en) 1984-05-16
PT77458B (en) 1986-02-26

Similar Documents

Publication Publication Date Title
AT381089B (de) Verfahren zur herstellung von neuen 3-amino-beta-lactam-1-sulfonsaeuren und ihren salzen
CH653993A5 (de) Zwischenprodukte, die zur herstellung von neuen 3-amino-beta-lactam-1-sulfonsaeuren und ihren salzen verwendbar sind.
DD250121A5 (de) Verfahren zur herstellung von 2-oxo-1(((substituiertes sulfonyl)-amino)-carbonyl)-azetidinen
DD213919A5 (de) Verfahren zur herstellung von beta-lactam derivaten
DE3013966A1 (de) 7- eckige klammer auf 2-(2-amino- 4-thiazolyl)-2- eckige klammer auf (1- carboxy-1,1-dialkyl)-alkoxyimino eckige klammer zu -acetamido eckige klammer zu -cephem-sulfoxide, verfahren zu ihrer herstellung, arzneimittel und verwendung
US4670553A (en) 2-oxo-1-(aminocarbonylaminosulfonyl-aminocarbonyl)azetidines
DD207907A5 (de) Verfahren zur herstellung von 2-oxo-1-(aminocarbonylaminosulfonylaminocarbonyl)-azetidinen
DE3781337T2 (de) 2-oxo-1-(((substituiertes sulfonyl)amino)-carbonyl)-azetidine.
DE3421785A1 (de) 3-acylamino-2-oxoazetidin-1-((beta)-oxopropionsaeuren) und ihre salze und ester
DD267035A5 (de) Verfahren zur herstellung von 2-aminooxy-2-propencarbonsaeure-verbindungen
DD222016A5 (de) Verfahren zur herstellung von neuen beta-lactam-antibiotika
DE3435998A1 (de) Azetidinone und ihre verwendung
DE3619911A1 (de) 3-acylamino-2-oxo-1-azetidin-sulfonsaeuren
DE3229439A1 (de) 2-oxo-1-((acylamino)-sulfonyl)-azetidine
DE3783159T2 (de) 2-oxo-1-(substituierte phosphorigsaeure)azetidine.
DE3822074A1 (de) 2-oxo-1-(((substituiertes sulfonyl)-amino)-carbonyl)-acetidine
DE3334984A1 (de) Neue ss-lactame
CA1244037A (en) (2-oxo-1-azetidinyloxy)-2-propenoic acid
DE3606584A1 (de) 8-oxo-2-oxa-1-azabicyclo(4.2.0)octan-3- carbonsaeure- und -essigsaeure verbindungen
US4889930A (en) Process for making 2-oxo-1-((substituted sulfonyl)amino)carbonzyl)azetidines and intermediates used therein
DE3440845A1 (de) Neue ss-lactame
DE3822100A1 (de) 2-oxo-1-(((substituiertes sulfonyl)-amino)-carbonyl)-acetidine
US4980465A (en) Process for making 2-oxo-1-[[(substituted sulfonyl)-amino]carbonyl)] azetidines and intermediates used therein
AT378367B (de) Verfahren zur herstellung von neuen 3-amino-beta-lactam-1-sulfonsaeuren und ihren salzen
DE3433676A1 (de) 3-acylamino-2-oxo-1-azetidinyl-ss- oxypropionsaeure-verbindungen und diese verbindungen enthaltende arzneimittel

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee